CN101129904B - Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula - Google Patents

Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula Download PDF

Info

Publication number
CN101129904B
CN101129904B CN2006100171373A CN200610017137A CN101129904B CN 101129904 B CN101129904 B CN 101129904B CN 2006100171373 A CN2006100171373 A CN 2006100171373A CN 200610017137 A CN200610017137 A CN 200610017137A CN 101129904 B CN101129904 B CN 101129904B
Authority
CN
China
Prior art keywords
parts
radix
peritonitis
empyema
portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2006100171373A
Other languages
Chinese (zh)
Other versions
CN101129904A (en
Inventor
张立梅
Original Assignee
张立梅
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 张立梅 filed Critical 张立梅
Priority to CN2006100171373A priority Critical patent/CN101129904B/en
Publication of CN101129904A publication Critical patent/CN101129904A/en
Application granted granted Critical
Publication of CN101129904B publication Critical patent/CN101129904B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a Chinese medicinal pill preparation for treating tuberculosis pleuritis, peritonitis, empyema and broncho-pleural fistula, which is prepared from 26 kinds of Chinese medicinal herbs including notoginseng, lily bulb, Sichuan fritillary bulb, lepidium seed, selfheal and weeping forsythia through steps of disintegrating, sieving, mixing homogenously, making water pills, and drying at low temperature.

Description

A kind of clear breast for the treatment of tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula consumptive disease ball of dispelling
Technical field:
The present invention relates to a kind of Chinese patent medicine that is used for the treatment of tuberculous pleuritis in clinical specially, particularly relate to a kind of to Western medicine drug resistance, allergy, the Chinese patent medicine of cureless tuberculous pleuritis, peritonitis, encysted pleurisy, tuberculous empyema and bronchopleural fistula.
Background technology:
Tuberculous pleuritis, peritonitis, encysted pleurisy, tuberculous empyema and bronchopleural fistula are commonly encountered diseases and frequently-occurring disease.Take western medicine and medical practitioners to treat and operative treatment for a long time always.Medicine mainly contains the antitubercular agent of Rimactazid, streptomycin, ethambutol, though these medicine clinical efficacies are relatively good, but side effect is very big, and it can cause the infringement to liver function, renal function, dysaudia, dizzy, gastrointestinal upset and anaphylaxis etc.And take medicine the back Chang Yi develop immunity to drugs, not obvious because of curative effect, affect the treatment, the extended treatment time.And operative treatment not only brings huge misery to the patient, also may cause some complication.
Summary of the invention:
The objective of the invention is to provide a kind of and replace western medicine and medical practitioners with Chinese medicine, evident in efficacy, patient's no pain, harmless to the bodily fuctions, audition there is not influence, do not produce the disease of various discomforts and other side effect, and specially the controlling the clear breast of the cureless tuberculous pleuritis of Western medicine (drug resistance, allergy), encysted pleurisy, peritonitis, tuberculous empyema, the bronchopleural fistula consumptive disease ball of dispelling of short treating period.
Technical scheme of the present invention is based on motherland's medical science to pathogenetic understanding of tuberculous pleuritis and treatment principle, with reference to the modern pharmacological research achievement, from motherland's medical treasure-house, filter out nourishing YIN and moistening the lung, bring down a fever promote the production of body fluid, diuretic by the drink, the pure natural plant medicine of promoting the circulation of QI and reducing phlegm, treating tuberculosis and killing worm, by the theory of Chinese medical science prescription, skim the cream off milk, make its performance blood-activating analgetic, nourishing YIN and clearing away heat, eliminating pathogens from lung for expelling fluid retention, the function for the treatment of tuberculosis and killing worm, thus thereby in treating tuberculosis and killing worm, blood-activating analgetic, nourishing YIN and clearing away heat, make hydrothorax absorb the purpose that reaches healing as early as possible.
The present invention is the medicament of being made by following component and weight proportion:
Radix Notoginseng 50-100 part Bulbus Lilii 30-50 part Bulbus Fritillariae Cirrhosae 30-50 part
Radix Ophiopogonis 30-50 part Flos Lonicerae 30-50 part Radix Platycodonis 15-25 part
Radix Scrophulariae 15-20 part Radix Peucedani 15-25 part Semen Armeniacae Amarum 20-30 part
Radix Codonopsis 50-100 part Folium Pyrrosiae 100-150 part Radix Angelicae Sinensis 30-50 part
Poria 30-50 part Semen Coicis 30-50 part Rhizoma Atractylodis Macrocephalae 30-50 part
Radix Gentianae 20-30 part Fructus Arctii 15-25 part Radix Paeoniae Alba 30-40 part
Radix Aucklandiae 20-30 part Semen Lepidii (Semen Descurainiae) 0-30 part Pseudobulbus Bletillae (Rhizoma Bletillae) 30-50 part
Radix Stemonae 50-100 part Rhizoma Picrorhizae 30-50 part Spica Prunellae 0-25 part
Radix Astragali 0-25 part Fructus Forsythiae 0-25 part.
Optimum weight proportioning of the present invention is:
50 parts of 50 parts of Bulbus Fritillariae Cirrhosaes of 100 portions of Bulbus Liliies of Radix Notoginseng 50 parts of Radix Ophiopogonis
25 parts of 20 parts of Radix Peucedanis of 25 portions of Radix Scrophulariaes of 50 parts of Radix Platycodoniss of Flos Lonicerae
50 parts of 150 parts of Radix Angelicae Sinensis of 100 parts of Folium Pyrrosiae of 30 parts of Radix Codonopsis of Semen Armeniacae Amarum
40 parts of 50 portions of Radix Paeoniae Albas of 50 parts of Rhizoma Atractylodis Macrocephalaes of 50 parts of Semen Coiciss of Poria
50 parts of 100 parts of Rhizoma Picrorhizae of 50 parts of Radixs Stemonae of 30 portions of Pseudobulbus Bletillae (Rhizoma Bletillae)s of the Radix Aucklandiae
25 parts of 30 parts of Fructus Arctii of Radix Gentianae.
Because described all sick main diseases are because of being due to deficiency of vital QI, being invaded by exogenous pathogen or illness worm are infected.Immoderate because of natural endowment weakness or addiction, or melancholy,anxiety and overstrain, or prolonged illness imbalance etc. cause the qi-blood-body fluid consumption to be hindered, and a little less than the premunition, exopathogen or illness worm are violated lung in an opponent's defence, Lung Qi obstraction, and gas is cloth Tianjin not, stops the breast side of body and is primary disease.Its morbidity emergency differs, and most onsets are rapid.Coerce at breast sick position, main dirty genus lung.This disease is this with the insufficiency of lung-QI, is mark with diseases caused by retention of fluid stop, the resistance of the channels stasis of blood.The total trend of its morbidity is the then sick few sun that begins, and can be converted into fluid-retention stagnating in the interior rapidly, with qi depression to blood stasis, the resistance of the channels stasis of blood, so based on the domination of pathogen.Therefore, by drink, assistant is with nourishing YIN and clearing away heat, treating tuberculosis and killing worm based on regulating qi to disperse stagnation in the present invention.Reuse the Radix Notoginseng blood-activating analgetic, alleviate pleural adhesion; Be aided with Bulbus Fritillariae Cirrhosae, Radix Ophiopogonis, Flos Lonicerae, Bulbus Lilii, Radix Scrophulariae, Radix Peucedani, Radix Platycodonis, Rhizoma Picrorhizae, Spica Prunellae, Semen Armeniacae Amarum nourishing YIN and moistening the lung, bring down a fever and promote the production of body fluid; By drink, promoting the circulation of QI and reducing phlegm absorbs in order to hydrothorax assistant with Folium Pyrrosiae, Semen Coicis, Poria, Semen Lepidii (Semen Descurainiae), the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Gentianae, Fructus Arctii, the Radix Aucklandiae, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Codonopsis, Fructus Forsythiae, diuretic; Make with Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Stemonae treating tuberculosis and killing worm.Group's medicine becomes the effect of regulating qi to disperse stagnation pain relieving, nourishing YIN and clearing away heat, eliminating pathogens from lung for expelling fluid retention, treating tuberculosis and killing worm altogether.
The present invention is raw material with the pure natural plant medicines, and the medicine source is extensive, and raw material is easy to get, and technology is simple, taking convenience, determined curative effect.It replaces Western medicine with Chinese medicine, change traditional therapeutic modality to tuberculous pleuritis, encysted pleurisy, peritonitis, tuberculous empyema, bronchopleural fistula, harmless to liver, kidney, without any side effects, body weight and immunocompetence obviously increase after clinical observation is taken medicine, hydrothorax, pus absorb fully, and parcel absorbs or dwindles.Compared with prior art, short treating period, instant effect does not recur, not only tuberculous pleuritis, peritonitis, encysted pleurisy, the empyema to drug resistance, allergy, refractory has quite significant curative effect, and also quite remarkable to the therapeutic effect of pleural adhesion and bronchopleural fistula.This medicine is present more satisfactory anti-tuberculosis drugs, has extensive promotional value.
The specific embodiment:
The present invention is a kind of Chinese patent medicine for the treatment of tuberculous pleuritis, peritonitis, encysted pleurisy, tuberculous empyema and bronchopleural fistula.It is produced by following method:
At first be by above-described optimum weight proportioning weighting raw materials (prepared slices of Chinese crude drugs), these 22 flavor prepared slices of Chinese crude drugs are ground into fine powder, or on the basis of preferred weight proportioning, the 26 flavor prepared slices of Chinese crude drugs that add 30 parts of Semen Lepidii (Semen Descurainiae)s, 25 parts of Spica Prunellaes, 25 parts of the Radixs Astragali, 25 parts of Fructus Forsythiaes are ground into fine powder, sieve respectively again, mixing, make water pill, cold drying makes.
Character of the present invention: this product is that light brown is to the dark-brown watered pill, feeble QI perfume (or spice), mildly bitter flavor.
Usage and consumption: oral.The 7-14 that is grown up restrains (1-2 bottle cap), 3 times on the one.7-9 year child 3 times on the one, one time 3.5 gram.The child is 3 times on the one more than 10 years old, one time 7 gram, warm water delivery service.
The present invention has blood-activating analgetic, nourishing YIN and clearing away heat, eliminating pathogens from lung for expelling fluid retention, the effect for the treatment of tuberculosis and killing worm.The alternate attack of chill and fever that in clinical, is used for the treatment of tuberculous pleuritis, peritonitis, encysted pleurisy, tuberculous empyema, bronchus breast fistula and causes, sputum mixed with blood, chronic cough, night sweat, feverish sensation in the palms and soles, sensation of oppression over the chest with shortness of breath, loss of appetite, become thin, disease such as weak.
The present invention suffers from tuberculous pleuritis, peritonitis, encysted pleurisy, tuberculous empyema and bronchopleural fistula lung patient's clinical experiment through Siping City tuberculosis hospital to 225 examples, has received well-content therapeutic effect.Now clinical data is reported as follows:
One, case is selected
We select 225 examples to experimentize in the patient that this institute goes to a doctor at random, wherein pleuritis 115 examples, peritonitis 32 examples, empyema 40 examples, bronchopleural fistula 18 examples, and in these cases, male's 108 examples account for 48%; Women's 117 examples account for 52%.Reckling is 6 years old in age, the maximum 79 years old, 39.67 years old mean age.59 examples below 20 years old wherein, 21-30 year 36 examples, 31-40 year 52 examples, 41-50 year 24 examples, 51-60 year 10 examples, 44 examples more than 61 years old.
Two, Therapeutic Method
Take the clear breast of the present invention consumptive disease ball of dispelling, each 3.5-7 gram or 7-14 gram, three times on the one, 30 days is a course of treatment, suspends to use and treat relevant medicine in treatment.Avoid raw meat, peppery and irritable food in the medication.
Three, criterion of therapeutical effect
1, recovery from illness: symptom is most of to disappear, and does not recur in 1 year, and corresponding main physico-chemical examination recovers normal substantially or is clearly better, x light and ultrasound diagnosis no abnormality seen, and the focus transudate disappears.
2, produce effects: cardinal symptom disappears, and half a year to one, a year main physico-chemical examination took a turn for the better, and x light and ultrasound diagnosis before are clearly better.
3, effective: cardinal symptom disappears substantially, the transudate basic absorption, and pachynsis pleurae is seen in the x optical test.
4, invalid: cardinal symptom no change, corresponding main physico-chemical examination no change.X light and ultrasound diagnosis no change or increase the weight of.
Four, observation of curative effect
Table 1 clinical experiment curative effect information slip
As seen, the present invention is 97% to treatment tuberculosis, encysted pleurisy effective percentage from table 1, is 94% to treatment peritonitis effective percentage, is 93% to treatment empyema effective percentage, is 89% to treatment bronchopleural fistula effective percentage, and comprehensive effective percentage is 93.25%.Meanwhile, we check routine urinalysis, liver function, renal function etc. to 225 routine part patients.The contrast review result has no significant change before and after taking medicine, and illustrates that this medicine has no side effect to liver, kidney and damages.
Doing well,improving information slip before and after table 2 225 routine patients take medicine
Show that by table 2 the present invention is to there being notable difference before and after the above-mentioned symptom medication.The p value is all less than 0.05.
Five, medical record is for example:
Liu, woman 39 years old, cadre, nineteen ninety-five first visit on May 15 cough, uncomfortable in chest in nearly month, happiness left lateral position.The X line: the bottom right pneumonoplueritis, drew water before the week 500 milliliters.Be diagnosed as tuberculous pleuritis.Took medicine one month, cough alleviates, no uncomfortable in chest, appetite has and increases weight increase.Obeyed again one month, and do not have cough, no uncomfortable in chest, sleep position freely.X line: right side pachynsis pleurae adhesion.
Six, summary conclusion:
The present invention cures mainly diseases such as tuberculous pleuritis, peritonitis, encysted pleurisy, peritonitis, tuberculous empyema, bronchopleural fistula and pachynsis pleurae adhesion.Really have the effect of blood-activating analgetic, nourishing YIN and clearing away heat, eliminating pathogens from lung for expelling fluid retention, treating tuberculosis and killing worm through clinical experiment, hydrops is absorbed voluntarily, the characteristics that the pachynsis pleurae adhesion is alleviated.This invention is for pure Chinese medicinal preparation, and the medicine source is extensive, and raw material is easy to get, taking convenience, and to liver, kidney is harmless and toxic and side effects, has obtained better therapeutic effect in clinical, its determined curative effect is suitable for promoting, and is worth wide clinical application.

Claims (1)

1. a clear breast for the treatment of pleuritis, peritonitis, tuberculous empyema and bronchopleural fistula consumptive disease ball of dispelling, it is characterized in that: it is the medicament of being made by following component and weight proportion:
50 parts of 50 parts of Bulbus Fritillariae Cirrhosaes of 100 portions of Bulbus Liliies of Radix Notoginseng 50 parts of Radix Ophiopogonis
25 parts of 20 parts of Radix Peucedanis of 25 portions of Radix Scrophulariaes of 50 parts of Radix Platycodoniss of Flos Lonicerae
50 parts of 150 parts of Radix Angelicae Sinensis of 100 parts of Folium Pyrrosiae of 30 parts of Radix Codonopsis of Semen Armeniacae Amarum
40 parts of 50 portions of Radix Paeoniae Albas of 50 parts of Rhizoma Atractylodis Macrocephalaes of 50 parts of Semen Coiciss of Poria
50 parts of 100 parts of Rhizoma Picrorhizae of 50 parts of Radixs Stemonae of 30 portions of Pseudobulbus Bletillae (Rhizoma Bletillae)s of the Radix Aucklandiae
25 parts of 30 parts of Fructus Arctii of Radix Gentianae.
CN2006100171373A 2006-08-25 2006-08-25 Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula Active CN101129904B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006100171373A CN101129904B (en) 2006-08-25 2006-08-25 Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100171373A CN101129904B (en) 2006-08-25 2006-08-25 Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula

Publications (2)

Publication Number Publication Date
CN101129904A CN101129904A (en) 2008-02-27
CN101129904B true CN101129904B (en) 2011-08-03

Family

ID=39127416

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100171373A Active CN101129904B (en) 2006-08-25 2006-08-25 Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula

Country Status (1)

Country Link
CN (1) CN101129904B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102228652B (en) * 2011-06-01 2012-10-31 刘青云 Chinese medicinal composition for treating chronic peritonitis and preparation method thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417100B (en) * 2008-12-09 2011-04-06 通化永仓药业有限公司 Medicine for treating secondary lung tuberculosis and preparation method thereof
CN102327525A (en) * 2011-10-13 2012-01-25 上海中医药大学附属岳阳中西医结合医院 Chinese medicinal composition for treating bronchiectasis
CN103316222B (en) * 2013-07-13 2014-06-11 华菊 Traditional Chinese medicine composition for treating pleurisy and preparation method thereof
CN103550488A (en) * 2013-10-18 2014-02-05 李越飞 Oral traditional Chinese medicine pill for treating cervical lymph node tuberculosis
CN104306838A (en) * 2014-08-06 2015-01-28 张立梅 Dampness-excreting tuberculosis-dispelling pill for treating pulmonary tuberculosis, tuberculous pleuritis and nephrophthisis
CN104306837A (en) * 2014-08-06 2015-01-28 张立梅 Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula
CN104689014A (en) * 2015-01-26 2015-06-10 青岛市中心医院 Preparation method of pleural lavage fluid
CN104606446A (en) * 2015-01-26 2015-05-13 青岛市中心医院 Pleural lavage fluid for treating post-traumatic acute pyothorax
CN104547821A (en) * 2015-01-26 2015-04-29 王海军 Perfusion solution for controlling malignant pleural effusion
CN105396002A (en) * 2015-11-23 2016-03-16 王雅芳 Formula for treating tuberculosis and making method
CN105641144A (en) * 2016-01-15 2016-06-08 王向丽 Traditional Chinese medicine for treating tuberculous encapsulated hydrothorax and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1243727A (en) * 1998-08-04 2000-02-09 张利梅 Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1243727A (en) * 1998-08-04 2000-02-09 张利梅 Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102228652B (en) * 2011-06-01 2012-10-31 刘青云 Chinese medicinal composition for treating chronic peritonitis and preparation method thereof

Also Published As

Publication number Publication date
CN101129904A (en) 2008-02-27

Similar Documents

Publication Publication Date Title
CN101129904B (en) Chest-clearing tuberculosis-dispelling pill for treating tuberculous pleurisy, peritonitis, empyema and bronchopleural fistula
CN101116733B (en) Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis
CN101912593B (en) Medicament for treating dysmenorrheal and preparation method thereof
CN101433654B (en) Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
CN101288729A (en) Chinese medicine granule for treating various dysmenorrhea
CN101797352A (en) Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof
CN101670011A (en) Medicament for treating rheumatism and rheumatoid and preparation method thereof
CN102423423B (en) Traditional Chinese medicine for treating urinary tract infection
CN103330826A (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN103599474A (en) Traditional Chinese medicinal composition for treating poor sleep quality
CN103211990A (en) Chinese medicinal composition for treating oral ulcer
CN103142722B (en) Traditional Chinese medicine composition for treating liver qi depression type irregular menstruation
CN104435519A (en) Pharmaceutical composition for treating primary dysmenorrhea
CN104623583A (en) Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid
CN104306838A (en) Dampness-excreting tuberculosis-dispelling pill for treating pulmonary tuberculosis, tuberculous pleuritis and nephrophthisis
CN101062340B (en) Chinese traditional medicine composition for liver revovery
CN102961662B (en) Medicine for treating gastric ulcer and preparation method thereof
CN104644956A (en) Traditional Chinese medicine composition for treating cold congealing and blood stasis type dysmenorrheal and preparation method thereof
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN104666880A (en) Nursing medicine for treating postpartum hypogalactia
CN101991703B (en) Traditional Chinese medicine for treating globus hysteriocus diseases
Huang et al. Novel Coronavirus Disease (COVID-19) Jīngfāng Prevention and Treatment Recommendations.
CN103599384A (en) Traditional Chinese medicinal preparation for treating hyperglycemia
CN103599386A (en) Traditional Chinese medicinal composition for treating diabetes
CN103585367A (en) Chinese medicinal composition for tranquilizing by nourishing heart

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant